Revistas de Psiquiatría
Pimavanserin for negative symptoms of schizophrenia: results from the ADVANCE phase 2 randomised, placebo-controlled trial in North America and Europe
The Lancet Psychiatry Fecha de publicación: 1 de enero de 2022 Autores: Dragana Bugarski-Kirola, MD , Prof Celso Arango, MD, Prof...
Association of school absence and exclusion with recorded neurodevelopmental disorders, mental disorders, or self-harm: a nationwide, retrospective, electronic cohort study...
Lancet Psychiatry Fecha de publicación: 1 de enero de 2022 DOI: https://doi.org/10.1016/S2215-0366(21)00367-9 Autores: Prof Ann John, MD , Yasmin Friedmann, PhD,...
Anxiety disorders and age-related changes in physiology
British Journal of Psychiatry Fecha de publicación: 6 de enero de 2022 Autores: Julian Mutz, Thole H. Hoppen, Chiara Fabbri...
Predicting relapse or recurrence of depression: systematic review of prognostic models
British Journal of Psychiatry Fecha de publicación: 11 de enero de 2022 Autores: Andrew S. Moriarty ,Nicholas Meader, Kym I....
Prevalence and Correlates of Cannabis Use and Cannabis Use Disorder Among U.S. Veterans: Results From the National Epidemiologic Survey on...
American Journal of Psychiatry Fecha de publicación: 19 de agosto de 2021 Autores: Kendall C. Browne, Ph.D., Malki Stohl, M.S., Kipling M. Bohnert, Ph.D., Andrew J....
Lo más popular
Maintenance Treatment With Long-Acting Injectable Antipsychotics for People With Nonaffect... 
Predicting relapse or recurrence of depression: systematic review of prognostic models 
Adverse Childhood Experiences: Implications for Offspring Telomere Length and Psychopathol... 
Economic evaluation of mindfulness group therapy for patients with depression, anxiety, st... 
Virtual-reality-based cognitive behavioural therapy versus waiting list control for parano... 
Web-based intervention for depressive symptoms in adults with types 1 and 2 diabetes melli... 
All for One and One for All: Mental Disorders in One Dimension